These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 24059692)

  • 1. Age-dependent effects of microglial inhibition in vivo on Alzheimer's disease neuropathology using bioactive-conjugated iron oxide nanoparticles.
    Glat M; Skaat H; Menkes-Caspi N; Margel S; Stern EA
    J Nanobiotechnology; 2013 Sep; 11():32. PubMed ID: 24059692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.
    Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM
    J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microglial activation arises after aggregation of phosphorylated-tau in a neuron-specific P301S tauopathy mouse model.
    van Olst L; Verhaege D; Franssen M; Kamermans A; Roucourt B; Carmans S; Ytebrouck E; van der Pol SMA; Wever D; Popovic M; Vandenbroucke RE; Sobrino T; Schouten M; de Vries HE
    Neurobiol Aging; 2020 May; 89():89-98. PubMed ID: 32008854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LPS- induced inflammation exacerbates phospho-tau pathology in rTg4510 mice.
    Lee DC; Rizer J; Selenica ML; Reid P; Kraft C; Johnson A; Blair L; Gordon MN; Dickey CA; Morgan D
    J Neuroinflammation; 2010 Sep; 7():56. PubMed ID: 20846376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease.
    Streit WJ; Braak H; Xue QS; Bechmann I
    Acta Neuropathol; 2009 Oct; 118(4):475-85. PubMed ID: 19513731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AMPK is abnormally activated in tangle- and pre-tangle-bearing neurons in Alzheimer's disease and other tauopathies.
    Vingtdeux V; Davies P; Dickson DW; Marambaud P
    Acta Neuropathol; 2011 Mar; 121(3):337-49. PubMed ID: 20957377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model.
    Helboe L; Egebjerg J; Barkholt P; Volbracht C
    Brain Res; 2017 Jun; 1665():22-35. PubMed ID: 28411086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microglial activation in brain lesions with tau deposits: comparison of human tauopathies and tau transgenic mice TgTauP301L.
    Sasaki A; Kawarabayashi T; Murakami T; Matsubara E; Ikeda M; Hagiwara H; Westaway D; George-Hyslop PS; Shoji M; Nakazato Y
    Brain Res; 2008 Jun; 1214():159-68. PubMed ID: 18457819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
    Padmanabhan J; Levy M; Dickson DW; Potter H
    Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rutin prevents tau pathology and neuroinflammation in a mouse model of Alzheimer's disease.
    Sun XY; Li LJ; Dong QX; Zhu J; Huang YR; Hou SJ; Yu XL; Liu RT
    J Neuroinflammation; 2021 Jun; 18(1):131. PubMed ID: 34116706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
    Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
    Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rifampicin is a candidate preventive medicine against amyloid-β and tau oligomers.
    Umeda T; Ono K; Sakai A; Yamashita M; Mizuguchi M; Klein WL; Yamada M; Mori H; Tomiyama T
    Brain; 2016 May; 139(Pt 5):1568-86. PubMed ID: 27020329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TLR2 immunotherapy suppresses neuroinflammation, tau spread, and memory loss in rTg4510 mice.
    Kim Y; Ryu SH; Hyun J; Cho YS; Jung YK
    Brain Behav Immun; 2024 Oct; 121():291-302. PubMed ID: 39098437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Piper sarmentosum Roxb. confers neuroprotection on beta-amyloid (Aβ)-induced microglia-mediated neuroinflammation and attenuates tau hyperphosphorylation in SH-SY5Y cells.
    Yeo ETY; Wong KWL; See ML; Wong KY; Gan SY; Chan EWL
    J Ethnopharmacol; 2018 May; 217():187-194. PubMed ID: 29462698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
    Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
    Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysfunctional microglia and tau pathology in Alzheimer's disease.
    Ayyubova G
    Rev Neurosci; 2023 Jun; 34(4):443-458. PubMed ID: 36302379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aggregated Tau activates NLRP3-ASC inflammasome exacerbating exogenously seeded and non-exogenously seeded Tau pathology in vivo.
    Stancu IC; Cremers N; Vanrusselt H; Couturier J; Vanoosthuyse A; Kessels S; Lodder C; Brône B; Huaux F; Octave JN; Terwel D; Dewachter I
    Acta Neuropathol; 2019 Apr; 137(4):599-617. PubMed ID: 30721409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minocycline reduces the development of abnormal tau species in models of Alzheimer's disease.
    Noble W; Garwood C; Stephenson J; Kinsey AM; Hanger DP; Anderton BH
    FASEB J; 2009 Mar; 23(3):739-50. PubMed ID: 19001528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of microglia or presence of peripherally-derived macrophages does not affect tau pathology in young or old hTau mice.
    Zhu K; Pieber M; Han J; Blomgren K; Zhang XM; Harris RA; Lund H
    Glia; 2020 Jul; 68(7):1466-1478. PubMed ID: 32039516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TREM2 modifies microglial phenotype and provides neuroprotection in P301S tau transgenic mice.
    Jiang T; Zhang YD; Chen Q; Gao Q; Zhu XC; Zhou JS; Shi JQ; Lu H; Tan L; Yu JT
    Neuropharmacology; 2016 Jun; 105():196-206. PubMed ID: 26802771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.